MethOxyfluraNe in InTerventiOnal Radiology (MONITOR): A randomised controlled trial
Ross Copping et al. J Med Imaging Radiat Oncol.2024.
https://pubmed.ncbi.nlm.nih.gov/38923825/
Results: One hundred and sixty-nine patients received methoxyflurane and 145 received placebo. Baseline characteristics were similar between the two groups. The methoxyflurane group had lower pain and anxiety scores throughout the procedure (P < 0.001) with 2.5 times less pain (VAS 1.08/10) and 1.6 times less anxiety (VAS 0.97/10) on average. Lower post-procedure pain (mean 0.72 vs 1.44; P < 0.001) and anxiety (mean 0.55 vs 1.13; P = 0.008) were also observed with methoxyflurane. There were no drug or major procedure-related adverse events.
Conclusion: The results of this study suggest that methoxyflurane provides safe and effective analgesia and anxiolysis for some procedures in IR.
MethOxyfluraNe in InTerventiOnal Radiology (MONITOR): A...
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
-0.005(1.16%) |
Mkt cap ! $47.87M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 44.0¢ | 42.0¢ | $35.10K | 81.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3150 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 29462 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |